ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,783Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 278

$969K Total Retail Price of All Prescriptions

Rank: 34 out of 278

451 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,486 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LISINOPRIL 774 558 1 5
LEVOTHYROXINE SODIUM 661 463 2 2
PRAVASTATIN SODIUM 591 399 3 16
OMEPRAZOLE 576 385 4 3
FUROSEMIDE 563 419 5 6
POTASSIUM CHLORIDE 399 305 6 17
HYDROCODONE-ACETAMINOPHEN 376 225 S3 7 1
LOVASTATIN 361 263 8 52
AMLODIPINE BESYLATE 360 260 9 7
WARFARIN SODIUM 355 284 10 11
METOPROLOL SUCCINATE 325 271 11 10
NEXIUM 313 208 12 14
METOPROLOL TARTRATE 302 201 13 9
GABAPENTIN 231 118 14 12
LANTUS 215 180 15 56
CLOPIDOGREL 191 158 16 20
ATENOLOL 187 146 17 18
GLIMEPIRIDE 179 107 18 28
FENTANYL 170 127 S2 19 82
CRESTOR 170 112 19 19
PROAIR HFA 169 82 21 34
METFORMIN HCL 169 119 21 8
CITALOPRAM HBR 167 121 23 21
ZOLPIDEM TARTRATE 163 64 24 26
DIGOXIN 157 145 25 40
ATORVASTATIN CALCIUM 156 97 26 13
NIASPAN 150 109 27 119
RAMIPRIL 141 128 28 81
PLAVIX 140 107 29 30
NAMENDA 139 139 30 48
ALLOPURINOL 139 115 30 38
TRAMADOL HCL 129 90 32 22
DEXILANT 118 47 33 84
CYCLOBENZAPRINE HCL 116 54 R 34 78
LOSARTAN POTASSIUM 109 91 35 24
CLONIDINE HCL 104 64 36 50
NOVOLOG 103 88 37 122
AZITHROMYCIN 100 45 38 39
SERTRALINE HCL 100 79 38 25
SIMVASTATIN 98 86 40 4
ISOSORBIDE MONONITRATE ER 98 67 40 33
MIRTAZAPINE 97 92 42 61
ALENDRONATE SODIUM 96 80 43 51
NASONEX 94 66 44 237
KLOR-CON M10 93 89 45 90
COMBIVENT 93 49 45 117
FAMOTIDINE 89 64 47 116
QUETIAPINE FUMARATE 88 53 48 80
INSULIN SYRINGE 85 46 49 72
LEVOFLOXACIN 83 73 50 66
HYDROCHLOROTHIAZIDE 83 70 50 15
POLYETHYLENE GLYCOL 3350 82 71 52 74
DOXYCYCLINE HYCLATE 81 54 53 145
FLUTICASONE PROPIONATE 81 45 53 44
CIPROFLOXACIN HCL 80 71 55 65
OXYBUTYNIN CHLORIDE 77 31 56 133
BENICAR 76 56 57 134
DILTIAZEM 24HR CD 75 57 58 95
AZOR 72 68 59 249
PANTOPRAZOLE SODIUM 72 51 59 36
DONEPEZIL HCL 71 71 61 29
VENLAFAXINE HCL ER 70 20 62 126
METHYLPREDNISOLONE 69 40 63 124
CARVEDILOL 69 55 63 23
CEFUROXIME 66 53 65 86
RANITIDINE HCL 65 51 66 27
FLUOXETINE HCL 65 35 66 68
MONTELUKAST SODIUM 64 43 68 96
SINGULAIR 64 44 68 60
ADVAIR DISKUS 63 39 70 45
LYRICA 62 29 71 67
ESCITALOPRAM OXALATE 60 48 72 63
PAROXETINE HCL 59 24 73 57
TAMSULOSIN HCL 58 32 74 32
LIVALO 58 48 74 328
BENICAR HCT 58 41 74 179
LIDODERM 58 43 74 215
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 36 78 31
NITROSTAT 55 44 78 156
SPIRONOLACTONE 54 39 80 62
PHENYTOIN SODIUM EXTENDED 54 31 80 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 41 80 98
TRAZODONE HCL 52 27 83 47
OXYCODONE HCL-ACETAMINOPHEN 50 0 S2 84 83
ROPINIROLE HCL 50 12 84 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.